SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-009555
Filing Date
2015-05-08
Accepted
2015-05-08 16:36:34
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20150331_10q.htm 10-Q 1002666
2 EXHIBIT 2.1 ex2-1.htm EX-2.1 683614
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 19151
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 18930
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 13037
  Complete submission text file 0001437749-15-009555.txt   6274939

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS bota-20150331.xml EX-101.INS 885677
7 EXHIBIT 101.SCH bota-20150331.xsd EX-101.SCH 34931
8 EXHIBIT 101.CAL bota-20150331_cal.xml EX-101.CAL 31690
9 EXHIBIT 101.DEF bota-20150331_def.xml EX-101.DEF 229273
10 EXHIBIT 101.LAB bota-20150331_lab.xml EX-101.LAB 208051
11 EXHIBIT 101.PRE bota-20150331_pre.xml EX-101.PRE 247537
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 15847337
SIC: 2836 Biological Products, (No Diagnostic Substances)